Lv11
40 积分 2024-04-19 加入
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
8小时前
已完结
IgGenix: engineering antibodies to fight food allergies
21天前
已完结
Accelerating discovery in natural science laboratories with AI and robotics: Perspectives and challenges
1个月前
已完结
Emerging 5-HT receptor antagonists for the treatment of Schizophrenia
1个月前
已完结
Telitacicept: First Approval
2个月前
已完结
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
2个月前
已完结
Two Trials of Therapeutics for MASH with Liver Fibrosis
2个月前
已完结
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
2个月前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2个月前
已完结
567. RL-007, a Novel Oral Neuromodulator, Reverses Cognitive Deficits Induced by Muscarinic Receptor Blockade in a Translational Model of Cognitive Impairment in Rats, Dogs and Humans
3个月前
已关闭
皖公网安备34019202002308
